Daily News: March 20, 2014

M*Modal Files Voluntary Chapter 11

JPMorgan private equity arm-owned M*Modal announced it filed voluntary petitions for relief under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York. Dechert is serving as legal counsel, Lazard Frères & Co. is serving as investment banker, and Alvarez & Marsal is serving as financial advisor to M*Modal.

M*Modal expects to use the Chapter 11 process to align the company’s debt structure with its vision, strategy and operations to better position the company for long-term success. The Company has been and remains in constructive discussions with its lenders and bondholders regarding the terms of a consensual financial restructuring plan and is focused on achieving a resolution as expeditiously as possible. M*Modal’s worldwide operations are expected to continue in the normal course throughout the restructuring process.

The company expects that its cash on hand, combined with funds generated from ongoing operations, will provide sufficient liquidity to continue operating in the ordinary course throughout this process.

Duncan James, M*Modal’s CEO, said, “When M*Modal was taken private in 2012, the acquisition was financed with a capital structure aligned with a specific set of assumptions that are no longer relevant. As a result, there is a need to restructure the company’s balance sheet to better align with changing market dynamics and refinements to our strategy. We intend to use the Court process to significantly strengthen M*Modal’s balance sheet and improve the Company’s financial flexibility by reducing our debt burden and establishing a capital structure that supports our investment in the future. Throughout this process we are not changing our operational execution or strategy, and our operations will continue as normal. Importantly, we will continue what we are known for: providing innovative technologies and offering healthcare providers a superior choice when selecting their clinical documentation and speech understanding technology partner. M*Modal has solid revenue, strong operating margins, cash flows consistent with industry norms, a large and growing customer base, and we are continuing to invest in the future. We intend to emerge with a strong financial footing so we can continue growing our market share and delivering innovative solutions to our customers.”

M*Modal is a healthcare technology provider of advanced clinical documentation solutions.

Previously on abfjournal, WSJ: JPMorgan Private Equity Arm-Owned Co. Prepares for Bankruptcy, March 10, 2014